From our list 9 new startups in Barcelona worth knowing (2026)
Flavii Therapeutics develops epigenetic treatments that act on the mechanisms controlling gene activity without changing DNA; its lead candidate FLAV-27 has shown promising preclinical results in models of Alzheimer's, Huntington's and autism. Founded in October 2025 as a spin-off from the University of Barcelona and led by co-founder and CEO Ariadna Boloix, with Aina Bellver as Chief Scientific Officer and professor Christian Griñán, it announced an 843,000 euro round led by Grow Venture Partners, with Institut Català de Finances and WA4STEAM, on 14 October 2026. Website: flaviitherapeutics.com. Source: Fundació Bosch i Gimpera, University of Barcelona.
Questions about Flavii Therapeutics
What does Flavii Therapeutics do?
Flavii Therapeutics: epigenetic medicines for brain disorders.
Where is Flavii Therapeutics based?
Flavii Therapeutics is based in Barcelona, Spain.
Where can I read more about Flavii Therapeutics?
Flavii Therapeutics is in our list 9 new startups in Barcelona worth knowing (2026): https://meetnewbrands.com/articles/new-startups-in-barcelona-2026